Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Autolus Limited
Mayo Clinic
Corvus Pharmaceuticals, Inc.
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
University of Pennsylvania
M.D. Anderson Cancer Center
BioInvent International AB
Children's Hospital Medical Center, Cincinnati
Ono Pharmaceutical Co. Ltd
Emory University
Prescient Therapeutics, Ltd.
Indiana University
Ohio State University Comprehensive Cancer Center
Sun Yat-sen University
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Washington University School of Medicine
Children's Hospital of Philadelphia
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Fudan University
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
M.D. Anderson Cancer Center
Vittoria Biotherapeutics
Columbia University
Mayo Clinic
Mayo Clinic
March Biosciences Inc
M.D. Anderson Cancer Center
SciTech Development, Inc.
City of Hope Medical Center
Takeda
University of Alabama at Birmingham
University of Virginia
Institute of Hematology & Blood Diseases Hospital, China
Autolus Limited
Institute of Hematology & Blood Diseases Hospital, China
The Lymphoma Academic Research Organisation
The Lymphoma Academic Research Organisation
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota